Clinical Trials on Primary Osteosarcoma of Bone in Spain

Total 610 results

Telios Pharma, Inc.

Recruiting

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

Primary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET Myelofibrosis

Spain, United States, France, Poland, Italy, Germany
Eli Lilly and Company

Completed

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

Leiomyosarcoma | Rhabdomyosarcoma | Synovial Sarcoma | Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET) | Adipocytic Sarcoma

United States, Germany, Poland, Belgium, Spain, France, Netherlands
Hospital Universitari Vall d'Hebron Research Institute
Erasme University Hospital; Cyprus Institute of Neurology and Genetics; EuroBloodNet...

Recruiting

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) (RADeep)

Iron Metabolism Disorders | Sickle Cell Disease | Thalassemia | Hemolytic; Anemia, Hereditary, Due to Enzyme Disorder | Anemia Due to Membrane Defect | CDA | Sideroblastic Anemia | Constitutional Aplastic Anemia | Hereditary Anemia

Spain
Asociacion para el Estudio de las Enfermedades...

Completed

Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA®) and Virologic Response to a CCR5 Antagonist in the Short Term (TROPISMVC)

HIV Infections

Spain
Hospital Carlos III, Madrid

Unknown

Simplification From Protease Inhibitors to Raltegravir (ODIS)

HIV Infections

Spain
Novartis Pharmaceuticals
Incyte Corporation

Terminated

A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis

Myelofibrosis

Spain, United Kingdom, Australia, Israel, Germany, Italy, Singapore, Austria, France
Marco Antonio Alvarez Gonzalez
Complejo Hospitalario de Navarra; Althaia Xarxa Assistencial Universitària...

Recruiting

Bowel Cleansing With Renal Impairment (BC-RIMP)

Renal Impairment | Adverse Effects of Medical Drugs

Spain
Novartis Pharmaceuticals

Active, not recruiting

Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients (ADORE)

Myelofibrosis

United Kingdom, Australia, Canada, Switzerland, Netherlands, Spain, Germany, Italy, Turkey, Russian Federation, Sweden, Denmark, Hungary
Fidia Farmaceutici s.p.a.

Completed

ONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder.

Non-Invasive Papillary Carcinoma of Bladder

Spain, Germany, Italy
University of Valencia
Instituto de Investigacion Sanitaria La Fe; Hospital Universitario La Fe

Recruiting

Therapeutic-educational Physiotherapy on Pain, Physical-functionality and Quality of Life in Women With Endometriosis. (PHYSIO_ENDOM)

Chronic Pain | Endometriosis | Women's Health

Spain
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV (FATHIV)

HIV Infections

Spain
Hospital Clinic of Barcelona
Hoffmann-La Roche

Completed

Metabolic Effects of Enfuvirtide in Healthy Volunteers

HIV Infections

Spain
Asociacion para el Estudio de las Enfermedades...

Completed

Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological Suppression (DOLBI)

HIV Infection

Spain
Judit Pich Martínez

Completed

A Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy

HIV-infection

Spain
Hospital de Cruces

Completed

Open Randomized Controlled Trial to Evaluate the Efficacy and Safety of Remifentanil Versus Nitrous Oxide in External Cephalic Version at Term in Singleton Pregnancy in Breech Presentation (REMIVER)

Pregnancy Complications | Inhalation of Nitrous Oxide | Complications; Cesarean Section | Non-cephalic Presentation | Fetus or Neonate Affected by External Version Before Labor

Spain
Hospitales Universitarios Virgen del Rocío
Instituto de Salud Carlos III

Completed

Tripe Versus Dual Antiretroviral Therapy in HIV-infected Patients With Virological Suppression (Tridual) (Tridual)

HIV Infections

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaborators

Completed

Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir

HIV Infections

Spain
Hospitales Universitarios Virgen del Rocío
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Unknown

Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral Therapy

HIV Infections

Spain
Hospital Clinic of Barcelona

Completed

Switching From PI to RALtegravir in HIV Stable Patients (SPIRAL)

HIV Infections

Spain
Gilead Sciences

Completed

GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance

HIV Infections

Spain
Instituto de Investigación Sanitaria de la Fundación...
Universidad Rey Juan Carlos

Completed

Guided Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence in Relapsing-Remitting Multiple Sclerosis

Urinary Incontinence | Relapsing-Remitting Multiple Sclerosis

Spain
Eli Lilly and Company

Recruiting

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Neoplasm Metastasis | Sarcoma, Ewing

United States, Australia, Spain, Japan, France, Italy, Germany
Pfizer
EMD Serono; Astellas Pharma Inc; Nektar Therapeutics

Terminated

Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors

Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)

Spain, United States, Poland, Belgium
Incyte Corporation

Completed

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

Polycythemia Vera | Myelofibrosis | Thrombocythemia

Spain, United States, Germany, Austria, Belgium, Italy, Poland
Fundacion para la Investigacion Biomedica del Hospital...
Merck Sharp & Dohme LLC

Completed

ARTiBIOME: Observational Study on the Effect of HIV and ART on Gut Microbiome

HIV Infections

Spain
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Randomized Placebo-controlled Pilot Trial of Prebiotics+Glutamine in HIV Infection (MicroVIH)

HIV

Spain
Hospital Clinic of Barcelona

Completed

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP) (RAL-PEP)

HIV Infection

Spain
Juan A. Arnaiz

Completed

Intermittent ART in Primary HIV Infection (PHI-IL2)

HIV

Spain
Hospitales Universitarios Virgen del Rocío

Completed

Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy (MonDar)

HIV-infection

Spain
Fundacion para la Investigacion Biomedica del Hospital...
Merck Sharp & Dohme LLC

Completed

Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1

HIV Infections | HIV-1

Spain
Asociacion Instituto Biodonostia

Recruiting

Impact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening (DICRA)

Uterine Cervical Neoplasms | Anxiety | Clinical Trial | Early Detection of Cancer

Spain
Hospitales Universitarios Virgen del Rocío

Unknown

Triple vs. Double Therapy in naïves HIV-Infected Patients (TRIDUNA)

HIV Infection

Spain
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Microbiota Restoration Therapy in HIV With Repeated Low-Dose Interventions (REFRESH)

HIV Infection

Spain
Hospital Clinic of Barcelona

Completed

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

HIV Infection

Spain
Juan A. Arnaiz

Completed

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD). (PHI-IMD)

HIV

Spain
Hospital Clinic of Barcelona

Completed

Dendritic Cell Vaccine in HIV-1 Infection

HIV Infections

Spain
Hospital Clinic of Barcelona

Unknown

Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression (RAL-dyn)

HIV Infection

Spain
Hospital Clinic of Barcelona

Suspended

Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic Failure

HIV Infection

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

HIV Infections

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

HIV Infections

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain

HIV Infections

Spain
Germans Trias i Pujol Hospital

Completed

Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product

HIV Infections

Spain
Germans Trias i Pujol Hospital
Hospital General Universitario Gregorio Marañon; Hospital Clinic of Barcelona; Carlos III Health Institute

Completed

Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients

HIV Infections

Spain
Manuel Luque Ramírez
Instituto de Salud Carlos III

Completed

Phlebotomy and Polycystic Ovary Syndrome

Hyperandrogenism | Metabolic Cardiovascular Syndrome

Spain
Alnylam Pharmaceuticals

Completed

A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Spain, United Kingdom
BCN Checkpoint
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaborators

Recruiting

Harm Reduction Program For Informal PrEP Users In A Community-based Setting (seguiPrEP) (seguiPrEP)

HIV Infections | Sexually Transmitted Diseases | HIV/AIDS | Adherence, Medication | Side Effect of Drug | Vaccination | Preexposure Prophylaxis

Spain
IVI Madrid

Withdrawn

Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population

Vitamin D Deficiency | Hormone Deficiency | Female Infertility Due to Diminished Ovarian Reserve | Follicular Cyst of Ovary

Spain
Inozyme Pharma

Recruiting

The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency

Generalized Arterial Calcification of Infancy | Autosomal Recessive Hypophosphatemic Rickets | Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency

United States, Turkey, United Kingdom, Spain, Canada, France, United Arab Emirates
Fundacion Clinic per a la Recerca Biomedica

Active, not recruiting

Safety, Tolerability, and Efficacy of a Dose Reduction Strategy Based on Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-infected Adults (BETAF-RED)

HIV Infections

Spain
ViiV Healthcare

Recruiting

Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant Women

HIV Infections

Spain

Clinical Trials on Primary Osteosarcoma of Bone in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations